Newstral
Article
DDaily News on 2016-09-01 22:33
NYC Controller Scott Stringer slams Mylan for EpiPen price hike
Related news
- MMylan CEO to answer for EpiPen price hikemoney.cnn.com
- Mylan Will Launch First Generic EpiPen At Half The Price After Outcry Over Price Hikehuffingtonpost.com
- Mylan CEO to speak about EpiPen price hike on CBS This MorningWCAX
- Mylan CEO defends EpiPen pricesKHQ Local News
- Mylan faces more congressional pressure to explain EpiPen price hikeWashington Post
- Crisis of the Week: Mylan Battles EpiPen Price Hike Criticismblogs.wsj.com
- Mylan launching cheaper, generic version of EpiPennwaonline.com
- Mylan CEO: EpiPen $608 Price Was 'Fair'wsj.com
- EpiPen price hike hits homeThe Press Democrat
- Mylan Executives Got Pay Increases As Price Of EpiPen Soaredhuffingtonpost.com
- Sanofi files U.S. antitrust lawsuit against Mylan over EpiPentriblive.com
- Mylan CEO set to defend EpiPen prices amid public outcrynewsobserver.com
- Updated: House panel: Mylan CEO minimized EpiPen profits in testimonyabqjournal.com
- Mylan paying a price for its EpiPen richesobserver-reporter.com
- House panel: Mylan CEO minimized EpiPen profits in testimonypost-gazette.com
- Mylan CEO to testify in hearing on EpiPen price increasesdothaneagle.com
- Mylan to pay $465M settlement over Medicaid EpiPen rebateskansascity.com
- Mylan to launch a cheaper, generic version of EpiPenLA Times
- Mylan to introduce a half-price generic version of EpiPenDallas News
- Mylan to pay $465 million settlement over Medicaid EpiPen rebatesChicago Tribune